NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Tata Elxsi Posts Mixed Quarter, Sees Modest Estimate Revisions

Tata Elxsi, a leading provider of design and technology services, reported revenue of USD109 million in its 4QFY26 quarter. The company's revenue growth of 0.9% quarter-on-quarter (QoQ) in constant currency (CC) terms fell short of Motilal Oswal's estimate of 2.0% CC.

The growth was led by Tata Elxsi's media and communication business, which saw an increase of 5.6% QoQ CC. However, the company's healthcare and life sciences (HLS) segment declined by 13.1% QoQ CC. On the profitability front, Tata Elxsi's earnings before interest and tax (EBIT) margin expanded to 22.3%, a 140 basis points (bps) increase from the previous quarter, surpassing Motilal Oswal's estimate of 20.4% EBIT margin.

The company's adjusted profit after tax (PAT) witnessed a significant growth of 23.1% and 27.8% QoQ and year-over-year (YoY) respectively, reaching INR2,204 million. This figure exceeded Motilal Oswal's estimate of INR1,841 million.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Estimate Revision and Outlook

Motilal Oswal has modestly revised its estimates for Tata Elxsi's FY27 and FY28 by 1%. The research firm expects the company's EBIT margin to expand gradually and towards the end of the fiscal year, reaching 23.7%. Based on its valuation model, Motilal Oswal values the stock at 22 times FY28 estimated earnings per share (EPS), with a target price (TP) of INR3,350.

Recommendation

Motilal Oswal reiterates its Sell rating on Tata Elxsi, reflecting the company's current valuation and outlook.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Investor Takeaway

Motilal Oswal recommends selling Tata Elxsi due to lower-than-expected revenue growth and maintains a target price of INR3,350.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.